V114 Pneumococcal Vaccine Has Acceptable Safety Profile for Infants

TUESDAY, June 13, 2023 -- VAXNEUVANCE (V114), the 15-valent pneumococcal conjugate vaccine (PCV) containing the 13 serotypes in Prevnar 13 (PCV13) plus serotypes 22F and 33F, is well-tolerated and safe for infants, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news